HEPATECT CP Israel - English - Ministry of Health

hepatect cp

kamada ltd, israel - human hepatitis b immunoglobulin - solution for infusion - human hepatitis b immunoglobulin 50 mg / 1 ml - immunoglobulins, normal human, for intravascular adm. - immunoglobulins, normal human, for intravascular adm. - prophylaxis against hepatitis b in adults and children over 2 years of age who have not been vaccinated against hepatitis b (including persons whose vaccination is incomplete or missing) who are at risk of infection with hepatitis b by accidental contact with hepatitis b virus containing material following: - percutaneous exposure (e.g. accidental needle stick). - direct mucous membrane contact. when the administration of an intramuscular hepatitis b immunoglobulin is not possible. the immunoglobulin should be administered in association with hepatitis b vaccine. prophylaxis against re-infection of a transplanted liver in patients who carry the surface antigen of the hepatitis b virus. immunoprophylaxis of hepatitis b in the newborn of a hepatitis b virus carrier mother.

Hepatect CP 50 IU/ml; solution for infusion Ireland - English - HPRA (Health Products Regulatory Authority)

hepatect cp 50 iu/ml; solution for infusion

biotest pharma gmbh - human plasma protein; hbs antibodies - solution for infusion - 50 international unit(s)/millilitre - specific immunoglobulins; hepatitis b immunoglobulin

HEPATECT CP SOLUTION FOR INFUSION 50 IUML Singapore - English - HSA (Health Sciences Authority)

hepatect cp solution for infusion 50 iuml

grifols asia pacific pte. ltd. - human hepatitis b immunoglobulin in 50mg/ml human plasma protein (igg ≥ 96%) - infusion, solution - 50 iu/ml - human hepatitis b immunoglobulin in 50mg/ml human plasma protein (igg ≥ 96%) 50 iu/ml